Core Insights - Rubicon Organics Inc. has appointed Glen Ibbott as Chief Financial Officer and Corporate Secretary, highlighting his extensive experience in the cannabis industry and previous role as CFO of Aurora Cannabis [1][2][3] Company Overview - Rubicon Organics is a licensed producer focused on cultivating and selling organic certified and premium cannabis products, positioning itself as a leader in the Canadian market [1][4] - The company operates a vertically integrated model with a strong national distribution network, featuring trusted brands such as Simply Bare™ Organics and 1964 Supply Co.™ [4] Leadership and Strategic Direction - Glen Ibbott brings over 25 years of leadership experience in publicly-traded life sciences and cannabis companies, having played a crucial role in Aurora Cannabis's growth and international expansion [3] - The CEO, Margaret Brodie, expressed confidence in Ibbott's strategic insight and financial acumen, which have already positively impacted the company's operations [2] Production and Capacity Expansion - Rubicon's production base is anchored by its Pacifica facility in Delta, BC, and is set to expand by over 40% with the acquisition and licensing of the Cascadia facility in Hope, BC [5] - The company is positioned to support future growth in both domestic and export markets through proprietary genetics and award-winning products [5] Market Position and Growth Potential - As the Canadian cannabis market rationalizes and global demand for high-quality cannabis increases, Rubicon's disciplined execution and brand equity differentiate it from competitors [6] - The company has demonstrated consistent revenue growth and positive Adjusted EBITDA, indicating strong operational performance and long-term growth potential [6]

Core Insights - Rubicon Organics Inc. reported record-breaking financial results for Q2 2025, achieving net revenue of $15.0 million, a 24% increase year-over-year, and a year-to-date (YTD) net revenue of $27.4 million, reflecting a 30% increase compared to the same period last year [3][8][9] Financial Performance - The company generated Adjusted EBITDA of $1.4 million for Q2 2025 and $2.1 million for the first half of 2025, marking positive Adjusted EBITDA for five consecutive quarters [3][9] - Operating profit reached $1.0 million for Q2 2025, with a net profit of $0.8 million, compared to a net loss of $0.5 million in the same quarter of the previous year [3][21] - Gross profit before fair value adjustments was $5.1 million for Q2 2025, with a gross profit margin of 34.2%, up from 30.2% in Q2 2024 [21] Production and Capacity Expansion - The acquisition of the Hope Facility was completed, increasing total production capacity by over 40%, bringing the total annual capacity to 15,500 kg of premium cannabis [8][12] - The Delta Facility is fully operational with an annual production capacity of 11,000 kg, and the company is focused on improving yield and quality [11][12] Market Position and Brand Strategy - Rubicon Organics holds a national market share of 5.2% in premium flower and pre-rolls, 15.1% in resin vapes, and 26.2% in premium edibles [9] - The company emphasizes its commitment to quality and innovation, with a focus on expanding its genetic portfolio and launching new products under its trusted brands [6][18] Future Outlook - The company anticipates continued growth in net revenue and Adjusted EBITDA for 2025, despite expected one-time costs associated with the Hope Facility [20] - Rubicon Organics aims to meet increasing domestic and international demand for premium cannabis while maintaining its focus on brand loyalty and consumer trust [10][14]